Physiotherapy and occupational therapy

Physiotherapy and occupational therapy has been studied in 1 paper since 2016: 1 trial in people. The newest paper, Jan 19, 2016: “Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on physiotherapy and occupational therapy

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“there was no difference between groups in NEADL total score (difference, 0.5 points; 95% CI, -0.7 to 1.7; P = .41)”
Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical TrialJAMA neurology2016doi:10.1001/jamaneurol.2015.4452
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: Department of Health and 1 more
  • Human trial1

Studies in people

1 study gave physiotherapy and occupational therapy to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on activities of daily living0.5 points; 95% CI -0.7 to 1.7; P = .41

Randomized trial3 months after randomization762 peoplemean 70 yearsOlder adults; mild to moderate Parkinson diseaseJAMA neurology, Jan 19, 2016

What did studies of physiotherapy and occupational therapy find?

1

Studies of physiotherapy and occupational therapy measured one outcome, activities of daily living.

Activities of daily living

no changein humans1

1 study
  1. Physiotherapy and occupational therapy showed no clear effect on activities of daily living in humans (mild to moderate Parkinson disease) (0.5 points; 95% CI -0.7 to 1.7; P = .41).

    “there was no difference between groups in NEADL total score (difference, 0.5 points; 95% CI, -0.7 to 1.7; P = .41)”

    Human trialmild to moderate Parkinson diseasemedian 4 visits of 58 minutes over 8 weeks3 months after randomizationn = 762

    Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial

    JAMA neurology

Latest